Table 2.
ED (N = 35) | Controls (N = 30) | p value | |
---|---|---|---|
Dynamic analysis | |||
Arterial dilation (%) | 1.88 ± 1.50 | 3.70 ± 1.56 | < 0.0001 |
Arterial constriction (%) | − 0.56 ± 1.22 | − 0.52 ± 1.54 | 0.430 |
Reaction amplitude (%) | 2.40 ± 2.02 | 4.25 ± 2.20 | 0.023 |
Venous dilation (%) | 2.79 ± 2.38 | 3.4 ± 2.96 | 0.241 |
Static analysis | |||
AVR | 0.98 ± 0.27 | 0.97 ± 0.21 | 0.127 |
CRAE | 252.1 ± 47.4 | 221.3 ± 56.6 | < 0.0001 |
CRVE | 259.3 ± 40.1 | 229.7 ± 43.2 | 0.024 |
Values are compared using a one-way analysis of covariance (ANCOVA) with age, diabetes, hypercholesterolemia and systemic hypertension as covariates. Data are presented as mean ± SD (standard deviation).
N number of patients, ED erectile dysfunction, AVR artery–vein ratio, CRAE central retinal artery equivalent, CRVE central retinal vein equivalent.